DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Faculty of Arts and Sciences
  3. FAS Theses and Dissertations
  4. Selective Elimination of Vibrio Pathogens via the Synergy of a Type Six Secretion System and a Natural Phenazine Antibiotic

Selective Elimination of Vibrio Pathogens via the Synergy of a Type Six Secretion System and a Natural Phenazine Antibiotic

Open/View files
supplemental 4.1.xlsx (1.14 MB)
Supplemental File 3.1.csv (69.77 KB)
  View More
Date
May 9, 2025
Author(s)
Bier, Sarah Beth
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Bier, Sarah Beth. 2025. Selective Elimination of Vibrio Pathogens via the Synergy of a Type Six Secretion System and a Natural Phenazine Antibiotic. Doctoral Dissertation, Harvard University Graduate School of Arts and Sciences.
Abstract
Vibrio species are most often studied in the context of human disease; multiple Vibrio species, including Vibrio cholerae, are widespread mammalian pathogens. In this work, we describe the isolation of a vibriocidal strain of Aeromonas dhakensis, named A603. We determine that its vibriocidal activity comes from a synergy between A603’s Type Six Secretion System and a synthesized phenazine antibiotic, AdPhen. Remarkably, non-Vibrio taxa resist this killing. We identify 3 systems in Vibrio strains that confer increased AdPhen resistance. However, A603’s T6SS activity overcomes efflux-mediated AdPhen resistance in newly generated V. cholerae mutants, likely through membrane potential dissipation and disruption of essential cation gradients. A603 uses both AdPhen and its T6SS to protect the host from invading Vibrio pathogens, like AHPND strains of V. parahaemolyticus. A603 guards aquatic hosts from AHPND-related microbiome disruptions without significant host colonization or changes to native flora. A603’s easy application, low colonization of hosts, and minimal alteration of microbiome composition or function makes it a promising new probiotic for prevention of vibriosis in aquatic hosts. While A603 itself cannot colonize mammalian hosts, the lessons learned from its activity can be leveraged to improve prophylaxis and treatment of Vibrio diseases, including cholera.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://dash.harvard.edu/handle/1/42719705
Subjects

A603

Aeromonas

cholera

microbiome

phenazine

Vibrio

Microbiology

Genetics

Molecular biology

Collection
FAS Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.